Russell Investments Group Ltd. lessened its holdings in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 13.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 176,529 shares of the basic materials company’s stock after selling 26,400 shares during the quarter. Russell Investments Group Ltd.’s holdings in DuPont de Nemours were worth $22,930,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Physician Wealth Advisors Inc. increased its stake in shares of DuPont de Nemours by 223.1% in the third quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company’s stock worth $27,000 after purchasing an additional 145 shares in the last quarter. Elevation Wealth Partners LLC raised its position in shares of DuPont de Nemours by 168.5% in the second quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company’s stock valued at $32,000 after purchasing an additional 150 shares during the period. DHJJ Financial Advisors Ltd. lifted its stake in shares of DuPont de Nemours by 150.0% during the 3rd quarter. DHJJ Financial Advisors Ltd. now owns 250 shares of the basic materials company’s stock valued at $32,000 after buying an additional 150 shares in the last quarter. Bangor Savings Bank purchased a new stake in shares of DuPont de Nemours during the 3rd quarter valued at approximately $36,000. Finally, Compass Wealth Management LLC purchased a new stake in shares of DuPont de Nemours during the 3rd quarter valued at approximately $39,000. Institutional investors own 73.96% of the company’s stock.
DuPont de Nemours Trading Down 0.0%
Shares of DD opened at $149.92 on Wednesday. The business’s 50-day moving average price is $136.09 and its 200-day moving average price is $139.53. DuPont de Nemours, Inc. has a twelve month low of $111.15 and a twelve month high of $159.48. The stock has a market cap of $19.87 billion, a PE ratio of 67.23, a P/E/G ratio of 1.30 and a beta of 1.06. The company has a quick ratio of 1.74, a current ratio of 2.36 and a debt-to-equity ratio of 0.23.
DuPont de Nemours Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend is Monday, November 30th. DuPont de Nemours’s dividend payout ratio is 107.62%.
Insider Buying and Selling
In other DuPont de Nemours news, Director Edward D. Breen sold 89,845 shares of the stock in a transaction that occurred on Thursday, November 5th. The shares were sold at an average price of $146.41, for a total value of $13,154,206.45. Following the sale, the director directly owned 127,276 shares in the company, valued at $18,634,479.16. This represents a 41.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Erik Hoover sold 4,203 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $150.82, for a total transaction of $633,896.46. Following the completion of the sale, the senior vice president owned 38,798 shares in the company, valued at $5,851,514.36. This represents a 9.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 96,359 shares of company stock valued at $14,137,411. Company insiders own 0.96% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts recently commented on the stock. The Goldman Sachs Group cut their price objective on shares of DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating for the company in a report on Wednesday, September 30th. Barclays boosted their target price on shares of DuPont de Nemours from $156.00 to $176.00 and gave the company an “overweight” rating in a report on Wednesday, November 4th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $172.00 to $145.00 in a research report on Friday, October 9th. Wells Fargo & Company raised their price target on DuPont de Nemours from $166.00 to $170.00 and gave the stock an “overweight” rating in a report on Thursday, November 5th. Finally, UBS Group raised their price target on DuPont de Nemours from $172.00 to $182.00 and gave the stock a “buy” rating in a report on Wednesday, November 4th. Twelve equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, DuPont de Nemours has a consensus rating of “Moderate Buy” and an average target price of $165.88.
View Our Latest Research Report on DD
DuPont de Nemours Profile
DuPont de Nemours is a science and materials company that develops products for customers in markets including construction, healthcare, water treatment, transportation and worker safety. Its offerings include protective materials such as Kevlar, Nomex and Tyvek, as well as Corian surface materials and technologies used in water purification and separation. The company traces its roots to 1802, when E. I. du Pont established a gunpowder mill in Delaware. Over time, DuPont expanded into a broad range of chemical and advanced-materials businesses.
Further Reading
- Five stocks we like better than DuPont de Nemours
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
